Regeneron Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 43.0% | 38.9% | 31.7% |
| FY2022 | 19.1% | 17.6% | 14.9% |
| FY2023 | 15.2% | 14.1% | 12.0% |
| FY2024 | 15.0% | 14.1% | 11.7% |
| FY2025 | 14.4% | 13.6% | 11.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 43.0% | 38.9% | 31.7% |
| FY2022 | 19.1% | 17.6% | 14.9% |
| FY2023 | 15.2% | 14.1% | 12.0% |
| FY2024 | 15.0% | 14.1% | 11.7% |
| FY2025 | 14.4% | 13.6% | 11.1% |